这种成分是什么?

이 원료는 다음의 구조를 갖는 탄화수소이다.

成分列表

成分词典

OCTENE

1-octene is an octene with an unsaturation C-1.

定义

1-octene is an octene with an unsaturation C-1.

来源: PubChem

美国FDA 物质登记 · UNII E5VK21B9RC · 登记名称 Caprylene · 单一化学物质

来源: 美国FDA 物质识别码（UNII）

化妆品中的作用

溶解其他成分的基质SOLVENT

安全与法规参考

韩国有毒物质 GHS 分类: 危险 · H304 (第1类) · H400 (第1类) · H410 (第1类) · 另有 1 项

来源: 韩国有毒物质 GHS 信息（环境公团）

详细资料——标示名称、识别编号、物性、试验记录、文献

别名和识别信息

OCTENEINCI옥텐韩国标示名称（食药处标准名）1-Octene同义名

CAS No.化学物质登记号: 111-66-0
EC No.欧盟化学品目录编号: 203-893-7
DTXSID美国EPA化学品编号: DTXSID6025804
DTXCID美国EPA化合物编号: DTXCID705804

IUPAC: Oct-1-ene
分子式: C8H16
分子量: 112.216 g/mol

实测物性

性状: 1-octene appears as a colorless liquid. Flash point 70 °F. Insoluble in water and less dense (at about 6 lb / gal) than water. Hence floats on water. Vapors are heavier than air and may settle in depressions. Reported to biodegrade very slowly. Used in organic synthesis, surfactants, and plasticizers. · Liquid
沸点: 250.3 °F at 760 mmHg (USCG, 1999) · 121.2 °C @ 760 mm Hg
熔点: -151 °F (USCG, 1999) · -101.7 °C
溶解性: Miscible with ethanol, ether · Miscible in ethanol, soluble in ethyl ether and acetone
密度: 0.715 at 68 °F (USCG, 1999) - Less dense than water, will float · 0.7149 @ 20 °C/4 °C
黏度: 0.656 cSt at 20 °C · 0.656 cSt (@ 20 ℃)
颜色: 无色
熔点/凝固点: -102 ℃
初沸点和沸程: 123 ℃
闪点: 10 ℃(c.c.)
易燃性（固体、气体）: 易燃
燃烧或爆炸范围上限/下限: 0.7 / 3.9 %
蒸气压: 17.4 ㎜Hg (@ 25 ℃)
溶解度: 4.1 ㎎/ℓ (@ 25 ℃)
蒸气密度: 3.9
比重: 0.7149 (@ 20 ℃)
正辛醇/水分配系数（Kow）: 4.57
自燃温度: 256 ℃
分子量: 112.22

这是对物质本身测得的数值。韩国安全保健公团（KOSHA）的资料仅供编写和审核安全数据表参考，并非原料商品的规格。

来源: PubChem · 韩国安全保健公团安全数据表

产品实际使用的用途

这是向美国 EPA 申报含该成分的 15 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。

Monomers3
Intermediate3
Flavouring and nutrient2
Chemical reaction regulator2
Viscosity modifier2
Lubricating agent1
Fragrance1
Solvent1

来源: 美国EPA CompTox

刺激与致敏试验记录

记录有皮肤试验 17 项、眼部试验 8 项。

归类为刺激性高5 项归类为中等3 项归类为低31 项

各项试验结论不一（最多的结论占 13%），因此不能断定该成分有刺激性。这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。

查看全部 25 项试验

Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Category 6.3A (Category 2)
Skin Irritation · Read Across
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) OPPTS 870.2500 according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Category 6.4A (Category 2A)
Eye Irritation · Read Across
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
Not classified
Eye Irritation · Screening
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to